CD8A and head and neck squamous cell carcinoma: Recently, Rahim et al.259 confirmed the central role that LNs play in shaping cancer patient response to immunotherapeutic treatment by studying CD8+ T cells from the primary tumors, blood, and regional LNs of head and neck squamous cell carcinoma patients.